Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Individual Patient Response from the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Apr. 8];8(1):s310. Available from: https://skin.dermsquared.com/skin/article/view/2546